Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 17, 2018

View Archived Issues

Total surveillance leads to cell division atlas

Mutations in IRF2BPL causes neurodegeneration in humans and flies

ASD diagnosis branches out

Cancer immunotherapy could get metabolic leg up

FDA approves Ajovy for preventive treatment of migraine

AstraZeneca adopts Horizon Discovery's Edit-R crRNA libraries for genomics discovery platform

Efgartigimod phase II data in ITP support progression to phase III development

Azitra, The Jackson Laboratory awarded grant to identify compounds for treatment of skin infections

Glenmark to use Mitra's CANscript platform in support of immuno-oncology pipeline

CymaBay opens enrollment in phase III study of seladelpar for primary biliary cholangitis

Palobiofarma enrolling patients in phase I study of PBF-1129 for NSCLC

Gilead Sciences and Precision BioSciences collaborate to develop therapies against HBV

MaxCyte studies MCY-M11 in phase I for advanced ovarian cancer and peritoneal mesothelioma

Zhejiang Beta Pharma patents fibroblast growth factor receptor inhibitors

AbbVie presents novel optimized GABA-B PAMs with efficacy in animal models of seizure

DGMIF presents DN-200434 for ATC radioiodine therapy improvement

Strategic alliance between Bayer and Evotec results in the discovery of BAY-2395840

Targeting alpha-4 integrin alleviates allergic conjunctivitis in animal models

First phase I data presented for inhaled pirfenidone

Bristol-Myers Squibb initiates two phase III trials of BMS-986165 in plaque psoriasis

Integrin alphaVbeta6 PET tracer shows promise for assessment of interstitial lung disease

Phase II data presented for CFTR potentiator QBW-251

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...